These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25765295)

  • 1. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea.
    Park KY; Hyun MY; Jeong SY; Kim BJ; Kim MN; Hong CK
    Dermatology; 2015; 230(4):299-301. PubMed ID: 25765295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The toxic edge-A novel treatment for refractory erythema and flushing of rosacea.
    Friedman O; Koren A; Niv R; Mehrabi JN; Artzi O
    Lasers Surg Med; 2019 Apr; 51(4):325-331. PubMed ID: 30311683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing.
    Al-Niaimi F; Glagoleva E; Araviiskaia E
    Dermatol Ther; 2020 Nov; 33(6):e13976. PubMed ID: 32633449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new treatment regimen for rosacea: onabotulinumtoxinA.
    Dayan SH; Pritzker RN; Arkins JP
    J Drugs Dermatol; 2012 Dec; 11(12):e76-9. PubMed ID: 23377526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled, split-face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea.
    Tong Y; Luo W; Gao Y; Liu L; Tang Q; Wa Q
    Dermatol Ther; 2022 May; 35(5):e15395. PubMed ID: 35187781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol for the treatment of refractory facial flushing and persistent erythema of rosacea.
    Hsu CC; Lee JY
    Arch Dermatol; 2011 Nov; 147(11):1258-60. PubMed ID: 21768447
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin blocks mast cells and prevents rosacea like inflammation.
    Choi JE; Werbel T; Wang Z; Wu CC; Yaksh TL; Di Nardo A
    J Dermatol Sci; 2019 Jan; 93(1):58-64. PubMed ID: 30658871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea: A Nonrandomized Controlled Trial.
    Wienholtz NKF; Christensen CE; Do TP; Frifelt LEW; Snellman J; Lopez-Lopez CL; Egeberg A; Thyssen JP; Ashina M
    JAMA Dermatol; 2024 Jun; 160(6):612-619. PubMed ID: 38630457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating rosacea with botulism toxin: Protocol for a systematic review and meta-analysis.
    He G; Yang Q; Wu J; Huang Y; Zheng H; Cheng H
    J Cosmet Dermatol; 2024 Jan; 23(1):44-61. PubMed ID: 37605478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea.
    Katz B; Patel V
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):6-8. PubMed ID: 16485874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline.
    Shanler SD; Ondo AL
    Arch Dermatol; 2007 Nov; 143(11):1369-71. PubMed ID: 18025359
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.
    Kim MJ; Kim JH; Cheon HI; Hur MS; Han SH; Lee YW; Choe YB; Ahn KJ
    Dermatol Surg; 2019 Sep; 45(9):1155-1162. PubMed ID: 30730346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.
    Luque A; Rojas AP; Ortiz-Florez A; Perez-Bernal J
    J Clin Aesthet Dermatol; 2021 Mar; 14(3):42-45. PubMed ID: 33841616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A split-face study using botulinum toxin type B to decrease facial erythema index.
    Oh YJ; Lee NY; Suh DH; Koh JS; Lee SJ; Shin MK
    J Cosmet Laser Ther; 2011 Oct; 13(5):243-8. PubMed ID: 21848448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of beta-blockers for rosacea-associated facial erythema and flushing: A systematic review and update on proposed mode of action.
    Logger JGM; Olydam JI; Driessen RJB
    J Am Acad Dermatol; 2020 Oct; 83(4):1088-1097. PubMed ID: 32360760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol.
    Pietschke K; Schaller M
    J Dermatolog Treat; 2018 May; 29(3):310-313. PubMed ID: 28748731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial flushing and erythema of rosacea improved by carvedilol.
    Seo BH; Kim DH; Suh HS; Choi YS
    Dermatol Ther; 2020 Nov; 33(6):e14520. PubMed ID: 33174351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin: 28 patients affected by Frey's syndrome treated with intradermal injections.
    Ferraro G; Altieri A; Grella E; D'Andrea F
    Plast Reconstr Surg; 2005 Jan; 115(1):344-5. PubMed ID: 15622288
    [No Abstract]   [Full Text] [Related]  

  • 19. A Pilot Study to Evaluate the Efficacy and Safety of Treatment with Botulinum Toxin in Patients with Recalcitrant and Persistent Erythematotelangiectatic Rosacea.
    Park KY; Kwon HJ; Kim JM; Jeong GJ; Kim BJ; Seo SJ; Kim MN
    Ann Dermatol; 2018 Dec; 30(6):688-693. PubMed ID: 33911508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea.
    Yang R; Liu C; Liu W; Luo J; Cheng S; Mu X
    Dermatol Ther (Heidelb); 2022 Oct; 12(10):2285-2294. PubMed ID: 35925473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.